Account
Publications
07.11.2022
ISPOR 2022 Plenary Session 1 - HTA and Regulation

Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...

Read more
Articles
03.08.2022
EU Joint HTA: How will EUNetHTA balance contrastin...

Our Market Access analysts summarise the EUnetHTA draft scoping process and provide considerations a...

Read more
Articles
28.06.2022
EU Joint HTA: How will EUNetHTA balance contrastin...

The EUNetHTA recently published its draft scoping guidance which outlines how the contrasting decisi...

Read more
Articles
05.12.2016
Theory of multiple criteria decision analysis

Multi-criteria decision analysis (MCDA) is a potentially useful tool that can be used to support dec...

Read more
Newer

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch